» Articles » PMID: 29860520

Specificity of RNAi, LNA and CRISPRi As Loss-of-function Methods in Transcriptional Analysis

Overview
Specialty Biochemistry
Date 2018 Jun 4
PMID 29860520
Citations 59
Authors
Affiliations
Soon will be listed here.
Abstract

Loss-of-function (LOF) methods such as RNA interference (RNAi), antisense oligonucleotides or CRISPR-based genome editing provide unparalleled power for studying the biological function of genes of interest. However, a major concern is non-specific targeting, which involves depletion of transcripts other than those intended. Little work has been performed to characterize the off-target effects of these common LOF methods at the whole-transcriptome level. Here, we experimentally compared the non-specific activity of RNAi, antisense oligonucleotides and CRISPR interference (CRISPRi). All three methods yielded non-negligible off-target effects in gene expression, with CRISPRi also exhibiting strong clonal effects. As an illustrative example, we evaluated the performance of each method for determining the role of an uncharacterized long noncoding RNA (lncRNA). Several LOF methods successfully depleted the candidate lncRNA but yielded different sets of differentially expressed genes as well as a different cellular phenotype upon depletion. Similar discrepancies between methods were observed with a protein-coding gene (Ch-TOG/CKAP5) and another lncRNA (MALAT1). We suggest that the differences between methods arise due to method-specific off-target effects and provide guidelines for mitigating such effects in functional studies. Our recommendations provide a framework with which off-target effects can be managed to improve functional characterization of genes of interest.

Citing Articles

Arrayed CRISPRi library to suppress genes required for Schizosaccharomyces pombe viability.

Ishikawa K, Soejima S, Nishimura T, Saitoh S J Cell Biol. 2024; 224(1).

PMID: 39378339 PMC: 11465072. DOI: 10.1083/jcb.202404085.


Large-scale multi-omic analysis identifies noncoding somatic driver mutations and nominates as a driver gene for pancreatic ductal adenocarcinoma.

Zhong J, OBrien A, Patel M, Eiser D, Mobaraki M, Collins I medRxiv. 2024; .

PMID: 39371173 PMC: 11451821. DOI: 10.1101/2024.09.22.24314165.


Targeting and engineering long non-coding RNAs for cancer therapy.

Coan M, Haefliger S, Ounzain S, Johnson R Nat Rev Genet. 2024; 25(8):578-595.

PMID: 38424237 DOI: 10.1038/s41576-024-00693-2.


Functional knockout of long non-coding RNAs with genome editing.

Lyu Q, Zhang S, Zhang Z, Tang Z Front Genet. 2023; 14:1242129.

PMID: 37705609 PMC: 10495571. DOI: 10.3389/fgene.2023.1242129.


LncRNA Functional Screening in Organismal Development.

Li Y, Zhai H, Tong L, Wang C, Xie Z, Zheng K Noncoding RNA. 2023; 9(4).

PMID: 37489456 PMC: 10366883. DOI: 10.3390/ncrna9040036.


References
1.
Smith I, Greenside P, Natoli T, Lahr D, Wadden D, Tirosh I . Evaluation of RNAi and CRISPR technologies by large-scale gene expression profiling in the Connectivity Map. PLoS Biol. 2017; 15(11):e2003213. PMC: 5726721. DOI: 10.1371/journal.pbio.2003213. View

2.
Gabory A, Ripoche M, Le Digarcher A, Watrin F, Ziyyat A, Forne T . H19 acts as a trans regulator of the imprinted gene network controlling growth in mice. Development. 2009; 136(20):3413-21. DOI: 10.1242/dev.036061. View

3.
Wei J, Zhang Z, Wynn R, Seemann J . GM130 Regulates Golgi-Derived Spindle Assembly by Activating TPX2 and Capturing Microtubules. Cell. 2015; 162(2):287-299. PMC: 4506739. DOI: 10.1016/j.cell.2015.06.014. View

4.
Lagarde J, Uszczynska-Ratajczak B, Carbonell S, Perez-Lluch S, Abad A, Davis C . High-throughput annotation of full-length long noncoding RNAs with capture long-read sequencing. Nat Genet. 2017; 49(12):1731-1740. PMC: 5709232. DOI: 10.1038/ng.3988. View

5.
Ingolia N, Ghaemmaghami S, Newman J, Weissman J . Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling. Science. 2009; 324(5924):218-23. PMC: 2746483. DOI: 10.1126/science.1168978. View